Letter From the JCTS Editor: Turning the Page
Once again, one year has changed into the next in an almost seamless transition. Well, maybe except for the weather – we have had nothing but rain in California for the first half of the month. Not that rain is not needed or welcome but as the saying goes, when it rains it pours – truly. Although many areas have suffered quite a lot, it might help at least somewhat in dealing with a relentless drought over the past years. In the long run, however, the need to take action to address drivers of climate change is getting more urgent every passing month.
The past year was an eventful year for JCTS. The number of submissions increased by about 40% and we are grateful to our colleagues who considered JCTS as an avenue for publications. A more detailed summary of the year’s activities will be presented in coming months. During 2022 we completed several thematic issues and we also issued a number of calls for new issues. Two of these, calls for Advancing Translational Science through Real-World Data and Real-World Evidence and Innovations for Enhancing the Informativeness and Quality of Clinical Trials are open for submissions to the end of the month while two others, Decentralized Research: Realizing the Promise of Virtual Clinical Trials and Well-Being in Clinical and Translational Science, are open until the end of March 2023. We have already received a number of submissions for these calls and there is still time to send in manuscripts.
Several new ideas for thematic issues are also being discussed and recently, we published a call for papers focused on the Integration of Social Determinants of Health (SDoH) with Clinical and Translational Science. The goal for the call is to stimulate submissions that highlight the integration of SDoH with clinical and translational science to understand the role of SDoH in health disparities and to develop SDoH-based intervention strategies to mitigate identified disparities, ultimately improving equity in health care and health outcomes. Social determinants of health are without doubt of key importance for both the spectrum of disease across population groups and the ability to access care as well strategies for prevention. The issue is open for submissions until the end of July, and we look forward to receiving manuscripts that address this important area.
As we are quickly getting into January, the timeline for the TS23 meeting is getting closer. The meeting last year was the first face-to-face meeting post COVID and it was really nice to get the opportunity to meet old and new friends and to see the exciting talks and posters. This year is promising to be another great opportunity to highlight advances in translational science and the schedule is available on the ACTS website. We are very excited that a JCTS Publication Award will be given for the first time underscoring the close relationship between the Association and the journal, and we hope that this will generate further interest. We encourage everyone to take the opportunity to participate in the meeting and look forward to see you there.
Lars Berglund, M.D., Ph.D., FAHA
Editor-in-Chief, Journal of Clinical and Translational Science (JCTS)
Translational Science 2023: Early Bird Registration
Don't wait— register now for Translational Science: Innovating Translational Science For Research taking place April 18-20, 2023 in Washington, DC!
Whether you're looking for insights to kick start your next research project, resources to advance your career, or time to explore new opportunities for collaboration, we've got you covered.
Register by Monday, February 13 to take advantage of early bird pricing. Register now.
News From the Hill: January 20, 2023
The 118th Congress convened with an uneven start. The Senate has been relatively uneventful with the chamber convening briefly to swear in a handful of newly elected Senators. On the other hand, the House struggled to elect a Speaker for nearly a week in a protracted political fight between moderate and far-right Republicans. While the leadership of key congressional committees has been announced, both chambers have yet to release complete committee rosters and to begin regular business.
Read more on the ACTS Advocacy page.
Do you know someone who deserves to be recognized for outstanding or groundbreaking work? Is your institution embarking on an exciting project? Send ACTS your story to be highlighted in future issues of the ACTS Connection.
Submit stories here.
The ACTS Career Center is the premier resource for connecting those in the field of translational science with career opportunities. Visit today to find a wealth of resources to help achieve your career goals.
ACTS members receive a 50% discount on the site—use code ACTSMEMBER to save!
Translational Science Today
Mount Sinai Researchers Awarded $12 Million NIH Grant to Create a Center to Unravel Novel Causes of Food Allergy and Atopic Dermatitis
Mount Sinai researchers have been awarded $12 million over five years by the National Institutes of Health to create a center to elucidate novel causes of, and contributing factors to, food allergies and atopic dermatitis. The Systems Biology of Early Atopy (SunBEAm) Analysis and Bioinformatics Center intends to develop a better understanding of allergy development.